| P50 | author | Carleen Cullinane | Q41678251 |
| | Rodney J. Hicks | Q43224607 |
| | Cinzia Imberti | Q58522338 |
| | Philip J Blower | Q60617592 |
| | Julia Baguña Torres | Q61106994 |
| | Samantha Y A Terry | Q83797938 |
| P2093 | author name string | Michelle T Ma | |
| | Peter Roselt | |
| P2860 | cites work | High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours | Q28260008 |
| | 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression | Q30497615 |
| | Iron binding dendrimers: a novel approach for the treatment of haemochromatosis | Q33248894 |
| | Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide | Q33668360 |
| | (44)Sc: an attractive isotope for peptide-based PET imaging. | Q34028144 |
| | Small molecule alpha(v) integrin antagonists: novel anticancer agents | Q34074899 |
| | Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals | Q34119201 |
| | Complexation of metal ions with TRAP (1,4,7-triazacyclononane phosphinic acid) ligands and 1,4,7-triazacyclononane-1,4,7-triacetic acid: phosphinate-containing ligands as unique chelators for trivalent gallium. | Q34119384 |
| | Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B. | Q35170338 |
| | Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer | Q37350456 |
| | Prospective of ⁶⁸Ga-radiopharmaceutical development | Q37435222 |
| | Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone) ligands | Q37594420 |
| | ⁶⁸Ga-labelled peptides for diagnosis of gastroenteropancreatic NET. | Q37990397 |
| | Matching chelators to radiometals for radiopharmaceuticals | Q38156660 |
| | [(68)Ga]FSC-(RGD)3 a trimeric RGD peptide for imaging αvβ3 integrin expression based on a novel siderophore derived chelating scaffold-synthesis and evaluation | Q38933775 |
| | Benefits of NOPO as chelator in gallium-68 peptides, exemplified by preclinical characterization of (68)Ga-NOPO-c(RGDfK). | Q39011647 |
| | Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors | Q39034927 |
| | Imaging integrin αvβ3 on blood vessels with 111In-RGD2 in head and neck tumor xenografts. | Q39035759 |
| | (18)F-glyco-RGD peptides for PET imaging of integrin expression: efficient radiosynthesis by click chemistry and modulation of biodistribution by glycosylation | Q39044773 |
| | PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate | Q39066068 |
| | (68)Ga small peptide imaging: comparison of NOTA and PCTA. | Q39266092 |
| | RGD conjugates of the H2dedpa scaffold: synthesis, labeling and imaging with 68Ga | Q39387478 |
| | 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging | Q39389586 |
| | Gallium-68 complex of a macrobicyclic cage amine chelator tethered to two integrin-targeting peptides for diagnostic tumor imaging | Q39482236 |
| | Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of α(ν)β(3) integrin expression and facile radiosynthesis | Q39505469 |
| | Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET. | Q39605627 |
| | Gallium labeled NOTA-based conjugates for peptide receptor-mediated medical imaging | Q39627974 |
| | (68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging | Q39861931 |
| | A triazacyclononane-based bifunctional phosphinate ligand for the preparation of multimeric 68Ga tracers for positron emission tomography. | Q42167262 |
| | Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaboration | Q42854505 |
| | The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy | Q43059527 |
| | Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma | Q43296875 |
| | NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors | Q43992775 |
| | Convenient preparation of 68Ga-based PET-radiopharmaceuticals at room temperature | Q46801081 |
| | Ethanol-Based Post-processing of Generator-Derived ⁶⁸Ga Toward Kit-Type Preparation of ⁶⁸Ga-Radiopharmaceuticals. | Q51740399 |
| | Be spoilt for choice with radiolabelled RGD peptides: preclinical evaluation of ⁶⁸Ga-TRAP(RGD)₃. | Q53140894 |
| | 68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors. | Q53277538 |
| | Structure and stability of hexadentate complexes of ligands based on AAZTA for efficient PET labelling with gallium-68 | Q60171678 |
| | Kinetics of Ga(NOTA) Formation from Weak Ga-Citrate Complexes | Q60319119 |
| | H2CHXdedpa and H4CHXoctapa—Chiral Acyclic Chelating Ligands for 67/68Ga and 111In Radiopharmaceuticals | Q60452051 |
| | Processing of generator-produced 68Ga for medical application. | Q64947317 |
| | TRAP, a powerful and versatile framework for gallium-68 radiopharmaceuticals | Q82836384 |
| | Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals | Q82995132 |
| | Simplified NaCl based (68)Ga concentration and labeling procedure for rapid synthesis of (68)Ga radiopharmaceuticals in high radiochemical purity | Q84512331 |
| | Unexpected sensitivity of sst2 antagonists to N-terminal radiometal modifications | Q84696636 |
| | How is (68)Ga labeling of macrocyclic chelators influenced by metal ion contaminants in (68)Ge/(68)Ga generator eluates? | Q85390972 |
| P433 | issue | 2 | |
| P304 | page(s) | 309-318 | |
| P577 | publication date | 2015-08-18 | |
| P1433 | published in | Bioconjugate Chemistry | Q2343023 |
| P1476 | title | New Tris(hydroxypyridinone) Bifunctional Chelators Containing Isothiocyanate Groups Provide a Versatile Platform for Rapid One-Step Labeling and PET Imaging with (68)Ga(3.). | |
| P478 | volume | 27 | |